Stay updated on Cabozantinib for Metastatic Pheochromocytomas Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page.

Latest updates to the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe study results have been posted to the study record (Results First Posted 2025-07-31). This update adds results-related information and references to publications.SummaryDifference0.4%

- Check21 days agoNo Change Detected
- Check42 days agoChange DetectedMajor change: version bump to v3.2.0 and an important operating-status notice about government funding and NIH Clinical Center, directing users to official sources.SummaryDifference3%

- Check49 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

- Check63 days agoChange DetectedUpdated page revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' link.SummaryDifference0.2%

- Check71 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check78 days agoChange DetectedThe web page has been updated to include a new facility name and location, along with relevant publications related to cabozantinib and a new version revision. Several previous location details and drug information have been removed.SummaryDifference4%

Stay in the know with updates to Cabozantinib for Metastatic Pheochromocytomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page.